Author Archives: Arun J. Sanyal, Brent A. Neuschwander-Tetri, James Tonascia
End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has emerged as a major cause of chronic liver disease in many parts of the world. It is associated with increased mortality owing to cardiovascular and liver disease and is also associated with an increased risk… Continue reading
Posted in News
Comments Off on End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease
End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) has emerged as a major cause of chronic liver disease in many parts of the world. It is associated with increased mortality owing to cardiovascular and liver disease and is also associated with an increased risk… Continue reading
Posted in News
Comments Off on End Points Must Be Clinically Meaningful for Drug Development in Nonalcoholic Fatty Liver Disease